Evidence map›Paper›PMID 31055786›Full record

ReviewMetabolic brain disease2019

Long non-coding RNAs and cell death following ischemic stroke.

Masoumeh Alishahi, Farhoodeh Ghaedrahmati, Tannaz Akbari Kolagar, William Winlow, Negin Nikkar, Maryam Farzaneh, Seyed Esmaeil Khoshnam

Abstract readReview
PubMed Publisher
In one paragraph

Review in Metabolic brain disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Neurovascular Unit: A critical role in ischemic stroke.CNS neuroscience & therapeutics · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Masoumeh AlishahiDepartment of Biology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Farhoodeh GhaedrahmatiDepartment of Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
Tannaz Akbari KolagarDepartment of Biology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
William WinlowDipartimento di Biologia, Università degli Studi di Napoli, Federico II, Via Cintia 26, 80126, Naples, Italy.
Negin NikkarDepartment of Biology, Faculty of Sciences, Alzahra University, Tehran, Iran.
Maryam FarzanehDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Seyed Esmaeil KhoshnamPhysiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Esmaeil.khoshnam1392@gmail.com.
Islamic Azad University North Tehran Branch · IRAcademic Center for Education, Culture and Research · IRAhvaz Jundishapur University of Medical Sciences · IRAlzahra University · IRShiraz University of Medical Sciences · IRUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is a major cause of morbidity and mortality worldwide, and extensive efforts have focused on the improvement of therapeutic strategies to reduce cell death following ischemic stroke. Uncovering the cellular and molecular pathophysiological processes in ischemic stroke have been a top priority. Long noncoding RNAs (lncRNAs) are endogenous molecules that play key roles in the pathophysiology of cerebral ischemia, and involved in the neuronal cell death during ischemic stroke. In recent years, a bulk of aberrantly expressed lncRNAs have been screened out in ischemic stroke insulted animals. LncRNAs along with their targets could affect the genetic machinery at molecular levels, and exploring their functions and mechanisms may be a promising option for ischemic stroke treatment. In this review, we summarize the current knowledge for lncRNAs in ischemic stroke, focusing on the role of specific lncRNAs that may underlie cell death to find possible therapeutic targets.

Indexed as

AnimalsBrainBrain IschemiaCell DeathHumansRNA, Long NoncodingStrokeRNA, Long NoncodingCell deathIschemic strokeLong non-coding RNA

Identifiers

PMID31055786
OpenAlexW2944523764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.